Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 107 publications
Letter: Beyond Feasibility-The Need for Longer Duration and Composite NIT Endpoints in Biopsy-Free MASH Trials: Authors' Reply.
Journal: Alimentary pharmacology & therapeutics
Published: June 02, 2026
Longitudinal Validation of Clinical Care Pathways for Metabolic Dysfunction-Associated Steatotic Liver Disease in a Prospective Cohort of Individuals With Type 2 Diabetes.
Journal: Gastro hep advances
Published: March 18, 2026
Global multicenter validation of noninvasive fibrosis assessment pathways in MetALD and ALD.
Journal: Hepatology communications
Published: February 25, 2026
Global Longitudinal Assessment of MASLD Using Magnetic Resonance Elastography (GOLDMINE): A Multi-Center, International Prospective Cohort Study of Imaging Biomarkers in MASLD Clinical Outcomes.
Journal: Alimentary pharmacology & therapeutics
Published: February 02, 2026
Letter on 'Inherited Genetic Risk of Liver Fibrosis in Lean Versus Nonlean Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)'; Authors' reply.
Journal: Alimentary pharmacology & therapeutics
Published: January 30, 2026
Histologic severity is identical between normal weight and overweight adults with MASLD: Implications for the definition of lean MASLD.
Journal: Hepatology communications
Published: January 17, 2026
Behavioral alcohol use disorder therapy in early liver transplant evaluation for alcohol-associated liver disease - a multicenter retrospective cohort study.
Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
Published: November 13, 2025
Spontaneous Recovery and Mortality in Patients With ALD Referred for Early Liver Transplantation.
Journal: The American journal of gastroenterology
Published: November 08, 2025
Clinical Trial: Semaglutide Versus Placebo in NIT-Assessed MASH-A Multicenter Randomised Placebo-Controlled Trial (SAMARA).
Journal: Alimentary pharmacology & therapeutics
Published: November 03, 2025
Editorial: Comparable Hepatic Fibrosis Risk Demands Equal Vigilance in Lean and Non-Lean Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease-Authors' Reply.
Journal: Alimentary pharmacology & therapeutics
Published: October 31, 2025
Factors associated with protection from MASLD in type 2 diabetes: A prospective study integrating longitudinal MRI/MRE and stable isotope tracing.
Journal: JHEP reports : innovation in hepatology
Published: October 20, 2025
Correction: Disparities in liver transplant waitlist characteristics and outcomes among Hispanic compared to non-Hispanic adults.
Journal: Frontiers in transplantation
Published: October 08, 2025
Last Updated: 09/26/2026